Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Female × iniparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 4 Neoplasms 4 Breast Neoplasms 4 Recurrence 2 Ovarian Neoplasms 2 Hypersensitivity 2 Squamous Cell Lung Cancer 1 Solid Tumors 1 Neoplasm Metastasis 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer Female 1 Brain Neoplasms 1 Advanced Solid Tumors 1 Advance Solid Tumors 1

Interventions

Tamoxifen 3 Exercise 3 pyrotinib 2 abemaciclib 2 Paclitaxel 2 Metformin 2 Cyclophosphamide 2 Capecitabine 2 Bupivacaine 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 palbociclib 1 iniparib 1 exemestane 1 durvalumab 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Tumor Burden 1 Tretinoin 1 Trastuzumab 1 Tocopherols 1 Thioctic Acid 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Sodium Chloride 1 Self-Help Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01204125 2017-03-22

SOLTI NEOPARP

Sanofi

Phase 2 Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡